Key Takeaways
- PZ Cussons plc (LON:PZC) has upgraded profit guidance twice in the past year, now expecting FY26 adjusted operating profit at or slightly above the top of its £53–57 million range.
- Net debt has fallen sharply, helped chiefly by the sale of its 50% stake in the PZ Wilmar edible-oils joint venture, with year-end net debt now expected below £30 million.
- Management has reversed an earlier plan to exit its wider African business, citing naira stabilisation and confidence in Nigeria's long-term growth, though currency volatility remains a risk.
- First-half results showed like-for-like revenue up 9.5% and adjusted operating profit up almost a third, with margin expansion across UK, Asia Pacific and African operations.
- PZ Cussons shares have re-rated in 2026, but trade on a modest earnings multiple versus consumer-goods peers, reflecting lingering caution about execution and Nigerian exposure.
Introduction
Few household names carry as much quiet history as PZ Cussons. Generations of Britons have washed with Imperial Leather soap or reached for a can of Carex without clocking the FTSE-listed group behind them. For much of the past decade, PZ Cussons (LON:PZC) has been a byword for underperformance, its sprawling portfolio and volatile Nigerian exposure repeatedly dragging on results.
That narrative has been shifting. Over the past eighteen months the group has sold a non-core Nigerian joint venture, U-turned on a plan to exit Africa altogether, reshaped its brand priorities, and delivered two successive upgrades to profit guidance. The question is whether that amounts to a genuine turnaround or a cyclical bounce helped by a calmer Nigerian currency and one-off disposal proceeds. The evidence points to a business making real progress that has not yet eliminated the exposures behind its earlier troubles.
Company Background and Business Model
PZ Cussons traces its origins to 1879, when George Paterson Zochonis and George Cussons began trading in what is now Nigeria before building a UK manufacturing base. The modern group is listed on the London Stock Exchange and sits in the FTSE SmallCap index, having previously been a FTSE 250 constituent before its market value shrank amid prolonged underperformance.
The business spans personal care, baby care and home care brands, including Imperial Leather, Carex, Original Source, Sanctuary Spa, St.Tropez, Childs Farm, Cussons Baby and Rafferty's Garden, plus Morning Fresh and Radiant in Australia and New Zealand. In Africa it also sells electricals under Haier Thermocool.
Operationally the group reports across three regions — Europe & Americas, Asia Pacific, and Africa — with Nigeria the largest and most volatile African market. Management also talks of "four lead markets": the UK, Australia/New Zealand, Nigeria and Indonesia, which generate most group sales. Chief executive Jonathan Myers, who joined in 2020, has concentrated investment on a shortlist of "must-win" brands rather than spreading resource across the group's wider brand list, alongside a leaner regional structure to cut complexity.
FY26 Trading Update: Profit Upgrade, Debt Reduction and the Africa Rethink
The clearest evidence of change came in PZ Cussons' Q4 FY26 trading update, issued ahead of full-year results due on 6 August 2026. The company now expects adjusted operating profit for the year to 31 May 2026 "at, or slightly above, the upper end" of its guided £53–57 million range — up from £48–53 million at the start of the year. Reported revenue was expected at approximately £540 million, with like-for-like growth of around 6%, broad-based across all four lead markets.
More striking still was the balance sheet: net debt is expected below £30 million at year-end, down over £80 million versus FY25, driven mainly by the sale of PZ Cussons' 50% stake in PZ Wilmar, a Nigerian edible-oils joint venture. That deal, part of a wider portfolio review flagged in April 2024, completed in June 2025 for gross proceeds of around $70 million, with net proceeds of £47 million used to pay down debt.
More consequential was a decision the board chose not to take. Having signalled in April 2024 that it might exit its wider African operations, PZ Cussons confirmed in December 2025 it was dropping that plan. Management said offers received "did not reflect the inherent value of the business," citing double-digit African revenue growth, improving Nigerian currency conditions, favourable demographics, and roughly 80% of Nigerian revenue from brands holding number one or two positions — a lead reinforced, it argues, as multinational rivals scale back in Africa. That is management's own assessment, not an audited fact, but it shows how far strategy has shifted in two years.
Financial and Operational Performance
Interim results for the six months to November 2025, published in February 2026, give the fullest picture of the turnaround's substance. Revenue rose 8.0% reported (9.5% like-for-like) to £269.3 million, while adjusted operating profit jumped 31.9% to £35.6 million, lifting margin by 240 basis points to 13.2%. Net debt fell to £84.3 million, down £27.7 million from the FY25 year-end, with net debt to EBITDA at 1.1 times, inside management's 1.0–1.5 times target range.
Africa revenue rose 27.7% like-for-like to £79.1 million, driven by 30%-plus growth in Nigerian Family Care revenue as pricing combined with 12.7% volume growth, showing pricing has not destroyed volumes. Asia Pacific revenue grew 5.2% to £87.7 million, helped by Indonesia's Cussons Baby re-staging, while Europe & Americas rose a more modest 1.7% to £102.5 million, with Sanctuary Spa and Original Source the standout UK performers.
FY25 (to 31 May 2025) revenue was £513.8 million, down 2.7% reported but up 8.0% like-for-like, with adjusted operating profit of £54.9 million, a 10.7% margin, and net debt of £112.0 million — the base against which today's lower figure is measured. The FY25 dividend was held at 3.60p per share; the FY26 interim dividend was likewise held at 1.50p, paid 9 April 2026. A cost-savings programme should deliver £5–10 million in FY26, mostly reinvested in marketing rather than dropped to profit.
Industry and Macroeconomic Context
PZ Cussons operates in fiercely competitive fast-moving consumer goods categories — soap, shower gel, hand sanitiser, baby toiletries and household cleaning — against far larger multinationals including Unilever, Reckitt and Procter & Gamble, plus private-label competition from major retailers. UK consumers have faced years of cost-of-living pressure, squeezing spend even on low-ticket items, while input cost inflation remains a recurring sector theme.
Nigeria remains the macro variable that most distinguishes PZ Cussons from its FMCG peers. The naira's sharp devaluations in 2023 and 2024 previously produced large foreign-exchange losses and repeated guidance downgrades. Management's own language — "ongoing stability" in the naira and "financial guardrails" against future currency moves — acknowledges how disruptive prior volatility had been. It has also flagged the Middle East conflict as a potential source of cost inflation into FY27, while stating that mitigating actions are largely in place.
Competitive Position
PZ Cussons holds genuine strength in pockets rather than broad market leadership. Carex remains a leading UK hand-hygiene brand, Imperial Leather retains long-standing recognition, and in Nigeria the group's Family Care and personal care brands reportedly hold number one or two positions across most of that revenue — a lead reinforced, management argues, as international competitors reduce their African footprint. Childs Farm and Original Source hold credible positions in premium baby care and naturally positioned personal care, both higher-margin niches than mass-market soap and detergent.
Against this, PZ Cussons is a relative minnow next to Unilever or Reckitt in scale and marketing budgets, and past cuts to marketing spend arguably weakened brand equity now being expensively rebuilt.
Growth Catalysts
Continued naira stability would remove a recurring drag on reported earnings, letting local volume growth show through more cleanly in sterling terms. The reversed Africa exit gives management a cleaner runway to invest behind Nigerian brands rather than manage a disposal, while retained St.Tropez, under a US partnership with the Emerson Group, offers a route back to growth in a market that had suffered double-digit declines.
Balance-sheet repair from the PZ Wilmar disposal gives more flexibility for bolt-on acquisitions, prioritised in the UK and Australia alongside the progressive dividend policy. Premiumisation in Indonesia and further UK brand relaunches represent additional, more modest upside.
Risks
Operationally, the group remains reliant on executing a brand-relaunch strategy that has taken years to show through, having previously prioritised short-term margin protection over brand investment. Financially, despite debt reduction, margins remain below larger global FMCG peers, and part of the improvement reflects one-off disposal proceeds rather than pure operating leverage.
Currency risk centres overwhelmingly on Nigeria: further naira devaluation, capital controls, or renewed inflation could quickly reverse recent gains, as happened in 2023 and 2024. Market risk includes private-label encroachment in the UK and Australia, cost inflation linked to shocks such as the Middle East conflict, and consumers trading down amid cost-of-living pressure. Reported return on equity has also been negative recently, a legacy of past impairments.
Investor Considerations
The case for optimism rests on verifiable progress: two guidance upgrades within a year, a lower debt load, and first-half margin expansion across every segment. The case for caution is that much of the improvement is tied to a Nigerian currency backdrop the company does not control, and to a disposal that will not repeat. Shares have re-rated through 2026, including a roughly 7% single-day gain around the June profit upgrade, yet the stock trades on an earnings multiple unremarkable next to larger peers, reflecting lingering doubt about durability.
This article does not offer a recommendation to buy, sell or hold PZ Cussons shares; readers should weigh the company's own risk disclosures, the upcoming results on 6 August 2026, and their personal circumstances, ideally alongside independent financial advice.
Conclusion
Has management's turnaround plan revived PZ Cussons? The fairest answer, on the evidence available in July 2026, is that it is working, but not finished, and not yet stress-tested through another Nigerian currency shock. Profit upgrades, a much-reduced debt pile and broad-based first-half growth are real, verifiable achievements, not promises. Equally real is the group's continued dependence on one volatile market and a landscape dominated by far bigger rivals. PZ Cussons (LON:PZC) looks further along its recovery path than at any point in recent years, but its durability will be judged over several more reporting cycles, not one.


_11_17_2026_13_00_51_895454.jpg)



Please wait processing your request...